DOI QR코드

DOI QR Code

Association of a p53 Codon 72 Gene Polymorphism with Environmental Factors and Risk of Lung Cancer: a Case Control Study in Mizoram and Manipur, a High Incidence Region in North East India

  • Published : 2015.01.22

Abstract

Background: A very high incidence of lung cancer is observed in Mizoram and Manipur, North East India. We conducted a population based case control study to establish associations of p53 codon 72 polymorphisms and interactions with environmental factors for this high incidence. Material and Methods: A total of 272 lung cancer cases and 544 controls matched for age (${\pm}5years$), sex and ethnicity were collected and p53 codon 72 polymorphism genotypes were analyzed using a polymerase chain based restriction fragment length polymorphism assay. We used conditional multiple logistic regression analysis to calculate adjusted odds ratios and 95% confidence intervals after adjusting for confounding factors. Results: p53 Pro/Pro genotype was significantly associated with increased risk of lung cancer in the study population (adjusted OR=2.14, CI=1.35-3.38, p=0.001). Interactions of the p53 Pro/Pro genotype with exposure to wood smoke (adjusted OR=3.60, CI=1.85-6.98, p<0.001) and cooking oil fumes (adjusted OR=3.27, CI=1.55-6.87, p=0.002), betel quid chewing (adjusted OR=3.85, CI=1.96-7.55, p<0.001), tobacco smoking (adjusted OR=4.42, CI=2.27-8.63, p<0.001) and alcohol consumption (adjusted OR=3.31, CI=1.10-10.03, p=0.034) were significant regarding the increased risk of lung cancer in the study population. Conclusions: The present study provided preliminary evidence that a p53 codon 72 polymorphism may effect lung cancer risk in the study population, interacting synergistically with environmental factors.

References

  1. Bellini MF, Cadamuro ACT, Succi M, Proenca MA, SilvaAE (2012). Alterations of the TP53 gene in gastric andesophageal carcinogenesis. J Biomed Biotechnol, 2012,891-961.
  2. Cheng Z, Wang W, Song Y, Kang Y, Xia J (2012). hOGG1, p53 genes, and smoking interactions are associated with thedevelopment of lung cancer. Asian Pacific J Cancer Prev,13, 1803-8. https://doi.org/10.7314/APJCP.2012.13.5.1803
  3. D'Souza ND, Murthy NS, Aras RY (2013). Projection of cancer incident cases for India - till 2026. Asian Pac J Cancer Prev,14, 4379-86. https://doi.org/10.7314/APJCP.2013.14.7.4379
  4. Dagher Z, Garcon G, Billet S, et al (2006). Activation of differentpathways of apoptosis by air pollution particulate matter(PM2.5) in human epithelial lung cells (L132) in culture. Toxicology, 225, 12-24. https://doi.org/10.1016/j.tox.2006.04.038
  5. Azlin AH, Looi LM, Cheah PL (2014). Tissue MicroarrayImmunohistochemical Profiles of p53 and pRB inHepatocellular Carcinoma and Hepatoblastoma. Asian Pac J Cancer Prev, 15, 3959-63. https://doi.org/10.7314/APJCP.2014.15.9.3959
  6. Beckman G, Birgander R, Sjalander A, et al (1994). Is p53polymorphism maintained by natural selection? Hum Hered,44, 266-70. https://doi.org/10.1159/000154228
  7. Fan R, Wu MT, Miller D, et al (2000). The p53 codon 72polymorphism and lung cancer risk. Cancer EpidemiolBiomarkers Prev, 9, 1037-42.
  8. Ferlay J, Shin HR, Bray F, et al (2010). GLOBOCAN 2010, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No.10. Lyon, France: International Agency forResearch on Cancer, ???
  9. Ferlay J, Soerjomataram I, Ervik M, et al (2012). GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide:IARC Cancer Base No.11. Lyon, France: International Agency for Research on Cancer. ???
  10. Francisco G, Menezes PR, Eluf-Neto J, Chammas R (2011). Arg72Pro TP53 polymorphism and cancer susceptibility: a comprehensive meta-analysis of 302 case-control studies. Int J Cancer, 129, 920-30. https://doi.org/10.1002/ijc.25710
  11. Grochola LF, Zeron-Medina J, Meriaux S, Bond GL (2010). Single-nucleotide polymorphisms in the p53 signalingpathway. Cold Spring Harb Perspect Biol, 2, a001032.
  12. Hosgood HD, Boffetta P, Greenland S, et al (2010). In-home coal and wood use and lung cancer risk: a pooled analysisof the international lung cancer consortium. Environ Health Perspect, 118, 1743-7. https://doi.org/10.1289/ehp.1002217
  13. Husgafvel-Pursiainen K, Kannio A (1996). Cigarette smoking and p53 mutations in lung cancer and bladder cancer. Environ Health Perspect, 104, 553-6. https://doi.org/10.1289/ehp.96104s3553
  14. Ihsan R, Devi TR, Yadav DS, et al (2011). Investigation on the role of p53 codon 72 polymorphism and interactions with tobacco, betel quid, and alcohol in susceptibility to cancers in a high-risk population from North East India. DNA Cell Biology, 30, 163-71. https://doi.org/10.1089/dna.2010.1119
  15. Jung HY, Whang YM, Sung JS, et al (2008). Association study of TP53 polymorphisms with lung cancer in a Koreanpopulation. J Hum Genet, 53, 508-14. https://doi.org/10.1007/s10038-008-0278-y
  16. Karim S (2014). Clinicopathological and p53 gene alteration comparison between young and older patients with gastric cancer. Asian Pac J Cancer Prev, 15, 1375-9. https://doi.org/10.7314/APJCP.2014.15.3.1375
  17. Landi S, Gemignani F, Canzian F, et al (2006). DNA repair and cell cycle control genes and the risk of young-onset lung cancer. Cancer Res, 66, 11062-9. https://doi.org/10.1158/0008-5472.CAN-06-1039
  18. Levine AJ (1997). p53, the cellular gatekeeper for growth and division. Cell, 88, 323-31. https://doi.org/10.1016/S0092-8674(00)81871-1
  19. Li Y, Chang SC, Niu R, et al (2013). TP53 genetic polymorphisms,interactions with lifestyle factors and lung cancer risk: a casecontrol study in a Chinese population. BMC Cancer, 13, 607. https://doi.org/10.1186/1471-2407-13-607
  20. Li Y, Qiu LX, Shen XK, et al (2009). A meta-analysis of TP53 codon 72 polymorphism and lung cancer risk: evidence from15,857 subjects. Lung Cancer, 66, 15-21. https://doi.org/10.1016/j.lungcan.2008.12.009
  21. Lin X, Chen Y, Gong W, et al (2014). Geographic distribution and epidemiology of lung cancer during 2011 in Zhejiang Province of China. Asian Pac J Cancer Prev, 15, 5299-303. https://doi.org/10.7314/APJCP.2014.15.13.5299
  22. Lissowska J, Bardin-Mikolajczak A, Fletcher T, et al (2005). Lung cancer and indoor pollution from heating and cookingwith solid fuels. Am J Epidemiol, 162, 326-33. https://doi.org/10.1093/aje/kwi204
  23. Malakar M, Devi KR, Phukan RK, et al (2014). p53 codon 72 polymorphism interactions with dietary and tobacco related habits and risk of stomach cancer in Mizoram, India. Asian Pac J Cancer Prev, 15, 717-23. https://doi.org/10.7314/APJCP.2014.15.2.717
  24. Moll UM, Schramm LM (1998). p53-an acrobat in tumorigenesis.Crit Rev Oral Biol Med, 9, 23-37. https://doi.org/10.1177/10454411980090010101
  25. NCRP (2013). National Cancer Registry Programme, Three-yearreport of the population based cancer registries 2009-2011, (Incidence and Distribution of Cancer: Report of 25 PBCRs in India). Indian Council of Medical Research, Bangalore,India, ???, 154-79.
  26. Patel KR, Vajaria BN, Begum R, et al (2013). Associationbetween p53 gene variants and oral cancer susceptibility in population from Gujarat, West India. Asian Pacific J Cancer Prev, 14, 1093-100. https://doi.org/10.7314/APJCP.2013.14.2.1093
  27. Pfeifer GP, Denissenko MF, Olivier M, et al (2002). Tobacco smoke carcinogens, DNA damage and p53 mutations insmoking-associated cancers. Oncogene, 21, 7435-51. https://doi.org/10.1038/sj.onc.1205803
  28. Phukan RK, Ali MS, Chetia CK, Mahanta J (2001). Betel nut and tobacco chewing; potential risk factors of cancer ofoesophagus in Assam, India. Br J Cancer, 85, 661-7. https://doi.org/10.1054/bjoc.2001.1920
  29. Phukan RK, Narain K, Zomawia E, Hazarika NC, Mahanta J(2006). Dietary habits and stomach cancer in Mizoram, India.J Gastroenterol, 41, 418-24. https://doi.org/10.1007/s00535-006-1761-x
  30. Phukan RK, Saikia BJ, Borah PK, et al (2014). Role of householdexposure, dietary habits and glutathione s-transferases M1, T1 polymorphisms in susceptibility to lung cancer among women in Mizoram India. Asian Pac J Cancer Prev, 15,3253-60. https://doi.org/10.7314/APJCP.2014.15.7.3253
  31. Phukan RK, Zomawia E, Narain K, Hazarika NC, Mahanta J(2005). Tobacco use and stomach cancer in Mizoram, India. Cancer Epidemiol Biomarkers Prev, 14, 1892-6. https://doi.org/10.1158/1055-9965.EPI-05-0074
  32. Piao JM, Kim HN, Song HR, et al (2011). p53 codon 72polymorphism and the risk of lung cancer in a Koreanpopulation. Lung Cancer, 73, 264-7. https://doi.org/10.1016/j.lungcan.2010.12.017
  33. Pietsch EC, Humbey O, Murphy ME (2006). Polymorphisms inthe p53 pathway. Oncogene, 25, 1602-11. https://doi.org/10.1038/sj.onc.1209367
  34. Ren Y, Yin Z, Wan Y, et al (2013). P53 Arg72Pro and MDM2 SNP309 polymorphisms cooperate to increase lungadenocarcinoma risk in Chinese female non-smokers: a case control study. Asian Pac J Cancer Prev, 14, 5415-20. https://doi.org/10.7314/APJCP.2013.14.9.5415
  35. Riley T, Sontag E, Chen P, Levine A (2008). Transcriptional control of human p53-regulated genes. Nat Rev Mol Cell Biol, 9, 402-12. https://doi.org/10.1038/nrm2395
  36. Robles AI, Linke SP, Harris CC (2002). The p53 network in lungcarcinogenesis. Oncogene, 21, 6898-907. https://doi.org/10.1038/sj.onc.1205563
  37. Saikia BJ, Phukan RK, Sharma SK, Sekhon GS, Mahanta J(2014). Interaction of XRCC1 and XPD gene polymorphismswith lifestyle and environmental factors regardingsusceptibility to lung cancer in a high incidence population in North East India. Asian Pac J Cancer Prev, 15, 1993-9. https://doi.org/10.7314/APJCP.2014.15.5.1993
  38. Sharma JD, Kalita M, Nirmolia T, et al (2014). Cancer: scenario and relationship of different geographical areas of the globe with special reference to North East-India. Asian Pac J Cancer Prev, 15, 3721-9. https://doi.org/10.7314/APJCP.2014.15.8.3721
  39. Sjalander A, Birgander R, Kivela A, Beckman G (1995). p53 polymorphisms and haplotypes in different ethnic groups. Hum Hered, 45, 144-9. https://doi.org/10.1159/000154275
  40. Wang S, Lan X, Tan S, et al (2013). P53 codon 72 Arg/Propolymorphism and lung cancer risk in Asians: an updated meta-analysis. Tumor Biol, 34, 2511-20. https://doi.org/10.1007/s13277-013-0678-2
  41. Whibley C, Pharoah PD, Hollstein M (2009). p53 polymorphisms:cancer implications. Nat Rev Cancer, 9, 95-107. https://doi.org/10.1038/nrc2584
  42. Yan L, Zhang D, Chen C, et al (2009). TP53 Arg72propolymorphism and lung cancer risk: a meta-analysis.Int J Cancer, 125, 2903-11. https://doi.org/10.1002/ijc.24603

Cited by

  1. No association of TP53 codon 72 and intron 3 16-bp duplication polymorphisms with breast cancer risk in Chinese Han women: new evidence from a population-based case–control investigation vol.23, pp.1, 2018, https://doi.org/10.1186/s40001-018-0345-6